Medigene (Germany)
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Medigene (Germany), Germany, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
56%
Total
Publications
327
Total Open
Publications
184
Total
Citations
9.1K
Open Access
Percentage
56%
Total
Publications
327
Total Open
Publications
184
Total
Citations
9.1K
Breakdown
Publisher Open
28%
Both
21%
Other Platform Open
5%
Closed
46%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
60
Hybrid 25%
38
No Guarantees 36%
55
Other Platform Open
Other Internet 41%
34
Domain 36%
30
Institution 33%
27
Preprint 10%
8
Public 7%
6
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
DOI | Other Internet | 33 |
PubMed Central | Domain | 30 |
Technical University of Munich | Institution | 4 |
helmholtz-muenchen.de OAI-PMH Repository | Institution | 4 |
bioRxiv | Preprint | 4 |
Zenodo | Public | 3 |
Research Square | Preprint | 3 |
Ludwig-Maximilians-Universität München | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |
Figshare | Public | 3 |